Bachaar Arnaout, MD

Assistant Clinical Professor of Psychiatry; Director of Ambulatory Detoxification, Medical Director of the Psychosocial Residential Rehabilitation Treatment Program, VA Connecticut Healthcare System

Research Organizations

Alcoholism Treatment Center

Selected Publications

  • Levounis, P., Arnaout, B., eds. Handbook of Motivation and Change: A Practical Guide for Clinicians. American Psychiatric Publishing, Inc. 2010.
  • Arnaout, B., Petrakis, I. Sedative-Hypnotics and Anxiolytics. In Addiction Medicine: Science and Practice, ed. B. A. Johnson. Springer. 2010.
  • Arnaout, B., Martino, S. Fundamentals of Motivation and Change. In Handbook of Motivation and Change: A Practical Guide for Clinicians, eds. Levounis, P., Arnaout, B. American Psychiatric Publishing, Inc. 2010.
  • Arnaout, B., Petrakis, I. Diagnosing Comorbid Drug Use in Patients with Alcohol Use Disorders. Alcohol Research & Health. 2008, 31:148-154.
  • 1. Ralevski, E., Jane, J.S., O’Brien, E., Edens, E., Arnaout, B., Kerfoot, K., Keegan, K., Weiner, J., Russo, M., Petrakis, I. Mecamylamine for treatment of people with dual diagnosis of depression and alcohol dependence. Journal of Dual Diagnosis. 2013,
  • 2. Ralevski, E., O’Brien, E., Jane, J.S., Dwan, R., Dean, E., Edens, E., Arnaout, B., Keegan, K., Drew, S., Petrakis, I. Treatment with acamprosate in patients with schizophrenia spectrum disorders and comorbid alcohol dependence. Journal of Dual Diagnosi
  • 3. Hellerstein, D.J., Batchelder, S.T., Hyler, S., Arnaout, B., Toba, C., Benga, I., Gangure, D. Escitalopram versus placebo in the treatment of dysthymic disorder. International Clinical Psychopharmacology. 2010, 25:143-148.
  • 4. Arnaout, B., Batchelder, S., Rosenthal, R.N., Hyler, S.E., Hellerstein, D.J. Does a history of alcohol use disorder affect response to antidepressant medication in patients with dysthymic disorder? Journal of Dual Diagnosis. 2008, 4:377-393.
  • 5. Hellerstein, D.J., Batchelder, S., Hyler, S.E., Arnaout, B., Corpuz, V., Coram, L., Weiss, G. Aripiprazole as an adjunctive treatment for refractory unipolar depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2008, 32:744-750.

Edit this profile